当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:37.57亿  总市值:43.63亿
流通股本:3.64亿   总股本:4.23亿

同和药业(300636)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.44亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益227144.71万元,未分配利润53959.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产339086.88万元,负债111942.18万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入206,454,983.02722,138,705.43559,661,869.75381,754,020.7
营业总成本150,662,133.88599,899,694.96476,319,761.9326,536,126.62
营业利润49,031,953.9112,232,257.9489,219,398.5561,133,476.44
利润总额48,965,203.9112,500,347.8489,160,134.2161,074,212.1
净利润43,562,751.14105,983,257.1578,653,167.8657,030,832.71
其他综合收益----
综合收益总额43,562,751.14105,983,257.1578,653,167.8657,030,832.71
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,284,774,481.81,196,983,710.511,078,658,972.51664,824,476.11
非流动资产合计2,106,094,358.022,024,456,028.482,064,969,124.381,748,167,062.47
资产总计3,390,868,839.823,221,439,738.993,143,628,096.892,412,991,538.58
流动负债合计672,142,270.93701,711,148.17639,032,822.27688,432,813.5
非流动负债合计447,279,507.25293,279,466.55313,614,577.77347,197,104.01
负债合计1,119,421,778.18994,990,614.72952,647,400.041,035,629,917.51
归属于母公司股东权益合计2,271,447,061.642,226,449,124.272,190,980,696.851,377,361,621.07
股东权益合计2,271,447,061.642,226,449,124.272,190,980,696.851,377,361,621.07
负债和股东权益合计3,390,868,839.823,221,439,738.993,143,628,096.892,412,991,538.58
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计156,938,328.08810,706,854.65557,523,692.04398,088,809.65
经营活动现金流出小计127,194,738.95646,958,320.9451,794,553.46273,013,380.45
经营活动产生的现金流量净额29,743,589.13163,748,533.75105,729,138.58125,075,429.2
投资活动现金流入小计48,653,507.48162,411,077.5481,933,884.5581,307,100.36
投资活动现金流出小计197,329,756.62868,616,952.96783,379,769.12413,323,594.08
投资活动产生的现金流量净额-148,676,249.14-706,205,875.42-701,445,884.57-332,016,493.72
筹资活动现金流入小计304,950,0001,761,318,211.221,522,814,687.43347,608,950.26
筹资活动现金流出小计154,753,166.8806,059,009.75638,754,360.34195,722,039.69
筹资活动产生的现金流量净额150,196,833.2955,259,201.47884,060,327.09151,886,910.57
汇率变动对现金及现金等价物的影响1,553,427.991,822,579.37710,120.08-769,595.93
现金及现金等价物净增加额32,817,601.18414,624,439.17289,053,701.18-55,823,749.88
期末现金及现金等价物余额525,619,976.92492,802,375.74367,231,637.7522,354,186.69
最新报告期:2024-04-17
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华创证券郑辰0.410.53--2024-04-17
TOP↑